The Youden index and the optimal cut-point corrected for measurement error

The Youden index and the optimal cut-point corrected for measurement error
复制标题

DOI:
10.1002/bimj.200410133
复制
发表时间:
2005-08-01
影响因子:
1.7
通讯作者:
Schisterman, EF
Schisterman, EF
中科院分区:
生物学3区
文献类型:
--
作者:
Perkins, NJ;Schisterman, EF

文献摘要

被引文献

相似文献

随机测量误差可以削弱生物标志物区分患病和非患病群体的能力。生物标志物有效性的总体量度是约登指数,即灵敏度(正确分类患病个体的概率)与I特异性(错误分类健康个体的概率)之间的最大差异。我们提出了一种方法,用于估计约登指数和相关的最佳临界点的正态分布的生物标志物,校正正态分布的随机测量误差。我们还提供了这些校正估计的置信区间,使用三角洲方法和覆盖概率,通过模拟各种情况。将这些技术应用于生物标志物硫代巴比妥酸反应物质(TBARS),脂质过氧化的子产物的测量,已被提议作为心血管疾病的鉴别测量,在最佳临界点的诊断有效性增加了50%。这一结果可能会导致生物标志物,曾经天真地认为无效成为有用的诊断设备。
Random measurement error can attenuate a biomarker's ability to discriminate between diseased and non-diseased populations. A global measure of biomarker effectiveness is the Youden index, the maximum difference between sensitivity, the probability of correctly classifying diseased individuals, and I-specificity, the probability of incorrectly classifying health individuals. We present an approach for estimating the Youden index and associated optimal cut-point for a normally distributed biomarker that corrects for normally distributed random measurement error. We also provide confidence intervals for these corrected estimates using the delta method and coverage probability through simulation over a variety of situations. Applying these techniques to the biomarker thiobarbituric acid reaction substance (TBARS), a measure of sub-products of lipid peroxidation that has been proposed as a discriminating measurement for cardiovascular disease, yields a 50% increase in diagnostic effectiveness at the optimal cut-point. This result may lead to biomarkers that were once naively considered ineffective becoming useful diagnostic devices.